Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation
Open Access
- 15 May 2007
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 7 (6), 1648-1655
- https://doi.org/10.1111/j.1600-6143.2007.01823.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Treatment of Epstein–Barr Virus Infections: Chemotherapy, Antiviral Therapy, and ImmunotherapyPublished by Taylor & Francis Ltd ,2006
- Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantationBlood, 2005
- Cell Therapy of Stage IV Nasopharyngeal Carcinoma With Autologous Epstein-Barr Virus–Targeted Cytotoxic T LymphocytesJournal of Clinical Oncology, 2005
- Treatment of EBV-Related Post-Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV-Specific T CellsAmerican Journal of Transplantation, 2005
- Cellular Immunity to Epstein-Barr Virus in Liver Transplant Recipients Treated with Rituximab for Post-Transplant Lymphoproliferative DiseaseAmerican Journal of Transplantation, 2005
- Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative diseaseBlood, 2003
- Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8+ T-cell restorationBlood, 2002
- B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcomeBone Marrow Transplantation, 1999
- HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONAnnual Review of Immunology, 1997
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991